Our Swiss regulatory news feed continuously monitors Swissmedic publications and regulatory developments in Switzerland, curated for pharmaceutical sponsors and marketing authorisation holders (MAHs) seeking or maintaining authorisation in the Swiss market. The feed covers marketing authorisation procedures, variation requirements and Swiss-specific GMP/GDP guidance.
Analysis, whitepapers and regulatory roundups written by the Arex Advisor team — covering EU, Nordic, Swiss, UK and US markets.
Browse all articles →Never miss an update. Get regulatory roundups and expert insights delivered to your inbox.
Sign up here →Staffan Thunell
Founding partner
BSc Economics and BA
Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from positions as Founder, Chairman, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.